Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study

C. Bisschop; T. H. van Dijk; J. C. Beukema; R. L. H. Jansen; H. Gelderblom; K. P. de Jong; H. J. T. Rutten; C. J. H. van de Velde; T. Wiggers; K. Havenga; G. A. P. Hospers

doi:10.1245/s10434-017-5897-0

Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study

C. Bisschop, T. H. van Dijk, J. C. Beukema, R. L. H. Jansen, H. Gelderblom, K. P. de Jong, H. J. T. Rutten, C. J. H. van de Velde, T. Wiggers, K. Havenga, G. A. P. Hospers^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	2632-2638
Number of pages	7
Journal	Annals of Surgical Oncology
Volume	24
Issue number	9
DOIs	https://doi.org/10.1245/s10434-017-5897-0
Publication status	Published - Sep 2017

Keywords

COLORECTAL LIVER METASTASES
SYNCHRONOUS UNRESECTABLE METASTASES
PALLIATIVE RADIOTHERAPY
SURGERY
CHEMOTHERAPY
RESECTION
CHEMORADIOTHERAPY
MANAGEMENT
PROGNOSIS
OUTCOMES

Cite this

Bisschop, C., van Dijk, T. H., Beukema, J. C., Jansen, R. L. H., Gelderblom, H., de Jong, K. P., Rutten, H. J. T., van de Velde, C. J. H., Wiggers, T., Havenga, K., & Hospers, G. A. P. (2017). Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study. Annals of Surgical Oncology, 24(9), 2632-2638. https://doi.org/10.1245/s10434-017-5897-0

Bisschop, C. ; van Dijk, T. H. ; Beukema, J. C. ; Jansen, R. L. H. ; Gelderblom, H. ; de Jong, K. P. ; Rutten, H. J. T. ; van de Velde, C. J. H. ; Wiggers, T. ; Havenga, K. ; Hospers, G. A. P. / Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer : Long-Term Results of a Phase II Study. In: Annals of Surgical Oncology. 2017 ; Vol. 24, No. 9. pp. 2632-2638.

@article{49df7326a4654636b30fa1dd495406a7,

title = "Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study",

keywords = "COLORECTAL LIVER METASTASES, SYNCHRONOUS UNRESECTABLE METASTASES, PALLIATIVE RADIOTHERAPY, SURGERY, CHEMOTHERAPY, RESECTION, CHEMORADIOTHERAPY, MANAGEMENT, PROGNOSIS, OUTCOMES",

author = "C. Bisschop and {van Dijk}, {T. H.} and Beukema, {J. C.} and Jansen, {R. L. H.} and H. Gelderblom and {de Jong}, {K. P.} and Rutten, {H. J. T.} and {van de Velde}, {C. J. H.} and T. Wiggers and K. Havenga and Hospers, {G. A. P.}",

year = "2017",

month = sep,

doi = "10.1245/s10434-017-5897-0",

language = "English",

volume = "24",

pages = "2632--2638",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer, Cham",

number = "9",

}

Bisschop, C, van Dijk, TH, Beukema, JC, Jansen, RLH, Gelderblom, H, de Jong, KP, Rutten, HJT, van de Velde, CJH, Wiggers, T, Havenga, K & Hospers, GAP 2017, 'Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study', Annals of Surgical Oncology, vol. 24, no. 9, pp. 2632-2638. https://doi.org/10.1245/s10434-017-5897-0

Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer : Long-Term Results of a Phase II Study. / Bisschop, C.; van Dijk, T. H.; Beukema, J. C.; Jansen, R. L. H.; Gelderblom, H.; de Jong, K. P.; Rutten, H. J. T.; van de Velde, C. J. H.; Wiggers, T.; Havenga, K.; Hospers, G. A. P.

In: Annals of Surgical Oncology, Vol. 24, No. 9, 09.2017, p. 2632-2638.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer

T2 - Long-Term Results of a Phase II Study

AU - Bisschop, C.

AU - van Dijk, T. H.

AU - Beukema, J. C.

AU - Jansen, R. L. H.

AU - Gelderblom, H.

AU - de Jong, K. P.

AU - Rutten, H. J. T.

AU - van de Velde, C. J. H.

AU - Wiggers, T.

AU - Havenga, K.

AU - Hospers, G. A. P.

PY - 2017/9

Y1 - 2017/9

KW - COLORECTAL LIVER METASTASES

KW - SYNCHRONOUS UNRESECTABLE METASTASES

KW - PALLIATIVE RADIOTHERAPY

KW - SURGERY

KW - CHEMOTHERAPY

KW - RESECTION

KW - CHEMORADIOTHERAPY

KW - MANAGEMENT

KW - PROGNOSIS

KW - OUTCOMES

U2 - 10.1245/s10434-017-5897-0

DO - 10.1245/s10434-017-5897-0

M3 - Article

VL - 24

SP - 2632

EP - 2638

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 9

ER -

Bisschop C, van Dijk TH, Beukema JC, Jansen RLH, Gelderblom H, de Jong KP et al. Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study. Annals of Surgical Oncology. 2017 Sep;24(9):2632-2638. https://doi.org/10.1245/s10434-017-5897-0

Access to Document

10.1245/s10434-017-5897-0